MTA and Biodentine in Pulpotomized Primary Molars

Cristina Cuadros

Status and phase: Unknown; Phase 4

Conditions: Primary Molar Pulpotomy

Treatments: Other: Pulpotomy

Study type: Interventional

Funder types: Other

Identifiers

NCT01591278

UIC-ODP-1

Details and patient eligibility

About

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MTA and Biodentine when used as pulp dressings following pulpotomy in human primary molars.

Enrollment: 80 estimated patients

Sex: All

Ages: 4 to 9 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• molars showing:

  1. symptomless exposure of vital pulp by caries
  2. no clinical or radiographic evidence of pulp degeneration (excessive bleeding from the root canal, internal root resorption, inter-radicular and/or furcal bone destruction)
  3. the possibility of proper restoration of the teeth
  4. no physiological resorption of more than one-third of the root

Exclusion criteria

• presence of systemic pathology and any history of allergic reaction to latex, local anaesthetics or to the constituents of the test pulp dressing agents

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

80 participants in 2 patient groups

Pulp dressing agent

Experimental group

Treatment:

Other: Pulpotomy

Other: Pulpotomy

Pulp dressing

Active Comparator group

Description:

MTA

Treatment:

Other: Pulpotomy

Other: Pulpotomy